Table 2 Ophthalmologic outcome of historical cohort
ROP progression | Any stage ROP | Stage 1 ROP at first visit |
|---|---|---|
Newborns, n (%) | 248 | 237 (95.6) |
Aggressive Posterior ROP, n (%) | 3 (1.2) | |
Stage ≥2 at first examination, n (%) | 8 (3.2) | |
Stage 1 ROP at first examination, n (%) | 237 (95.6) | |
Stage 2, n (%) | 172 (69.3) | 165 (69.6) |
Stage 3, n (%) | 72 (29.0) | 68 (28.7) |
Stage 2 or 3 ROP with plus, n (%) | 63 (25.4) | 58 (24.5) |
Stage 4 ROP, n (%) | 4 (1.6) | 4 (1.7) |
Stage 5 ROP, n (%) | 1 (0.4) | 1 (0.4) |
Treatment with laser photocoagulation, n (%) | 47 (18.9) | 45 (19.0) |
Treatment with bevacizumab, n (%) | 30 (12.1) | 27 (11.4) |
Vitrectomy, n (%) | 4 (1.6) | 4 (1.7) |
Cryotherapy, n (%) | 1 (0.4) | 1 (0.4) |